Fanny Cavalié
Chief Operating Officer at FOGHORN THERAPEUTICS INC.
Net worth: 397 438 $ as of 2024-04-29
Profile
Fanny Cavalié is currently the Chief Strategy & Business Operations Officer at Foghorn Therapeutics, Inc. She previously worked at Biogen, Inc. as the Head-Multiple Sclerosis Portfolio Strategy from 2014 to 2018.
Prior to that, she was an Associate Partner at McKinsey & Co., Inc. (United Kingdom) from 2003 to 2014.
Ms. Cavalié holds an MBA from École des Hautes Études Commerciales de Paris, which she obtained in 2001.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-10 | 75,992 ( 0.18% ) | 397 438 $ | 2024-04-29 |
Fanny Cavalié active positions
| Companies | Position | Start |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Chief Operating Officer | - |
Former positions of Fanny Cavalié
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 2018-02-28 |
McKinsey & Co., Inc. (United Kingdom)
 McKinsey & Co., Inc. (United Kingdom) Investment ManagersFinance Part of McKinsey & Co., Inc., McKinsey & Co., Inc. (United Kingdom) is a consulting firm that helps UK manufacturers embrace new technologies for digital transformation and leadership. The company is based in London, UK. Ruben Schaubroeck, McKinsey Digital's new lead for the UK, Belgium, and Netherlands offices, spoke with Thomas Farrar, a manager of communications in the firm's UK office, about the importance of speed and pace for CEOs in this new growth journey. The British company works with organizations that pursue sustainability, inclusion, and economic growth, all at the same time, to achieve strategic foresight and built-in agility in the face of the COVID-19 pandemic and the new trading relationship with the EU. | Corporate Officer/Principal | 2014-04-30 |
Training of Fanny Cavalié
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| FOGHORN THERAPEUTICS INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Private companies | 1 |
|---|---|
McKinsey & Co., Inc. (United Kingdom)
McKinsey & Co., Inc. (United Kingdom) Investment ManagersFinance Part of McKinsey & Co., Inc., McKinsey & Co., Inc. (United Kingdom) is a consulting firm that helps UK manufacturers embrace new technologies for digital transformation and leadership. The company is based in London, UK. Ruben Schaubroeck, McKinsey Digital's new lead for the UK, Belgium, and Netherlands offices, spoke with Thomas Farrar, a manager of communications in the firm's UK office, about the importance of speed and pace for CEOs in this new growth journey. The British company works with organizations that pursue sustainability, inclusion, and economic growth, all at the same time, to achieve strategic foresight and built-in agility in the face of the COVID-19 pandemic and the new trading relationship with the EU. | Finance |
- Stock Market
- Insiders
- Fanny Cavalié
